165. Towards Gene Therapy for EBV-Associated Post-Transplant Lymphoproliferative Disease: Genetically Modified EBV-Specific Cytotoxic T Lymphocytes Induce Regression of Autologous EBV-Induced Lymphoproliferation Despite Immunosuppression [PDF]
, 2014 openalex +1 more source
S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy [PDF]
, 2014 Simon Grassmann +5 more
openalex +1 more source
Inhibition of glycolysis-driven immunosuppression with a nano-assembly enhances response to immune checkpoint blockade therapy in triple negative breast cancer [PDF]
, 2023 Xijiao Ren +8 more
openalex +1 more source
International Journal of Nephrology and Renovascular Disease, 2010 P Dalal1, G Shah1, D Chhabra2, Lorenzo Gallon21Department of Medicine, Mount Sinai Hospital, Chicago; 2Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USAIntroduction: Several new medications are now available for ...
P Dalal, G Shah, D Chhabra, et al
doaj
Impact of a New Fusion Receptor on PD-1–Mediated Immunosuppression in Adoptive T Cell Therapy [PDF]
, 2015 Sebastian Kobold +12 more
openalex +1 more source
Reactivation of hepatitis B virus associated with immunosuppression therapy. [PDF]
CMAJ, 2018 Lee JGH, Carruthers M, Ko HH.
europepmc +1 more source
Optimal switching strategies in multi-drug therapies for chronic diseases [PDF]
arXivAntimicrobial resistance is a threat to public health with millions of deaths linked to drug resistant infections every year. To mitigate resistance, common strategies that are used are combination therapies and therapy switching. However, the stochastic nature of pathogenic mutation makes the optimization of these strategies challenging.
arxiv